Runowicz, Carolyn

Edit Your Profile

Runowicz, Carolyn

Positions

Professor, College of Medicine - Office of Academic Affairs , Herbert Wertheim College of Medicine

placeholder image

Patents issued

On-Demand Drug Release Using Magneto-Electric Nanoparticles Patent

selected scholarly works & creative activities

Article
- 2021
  
  Association Between Race/Ethnicity and Survival in Women With Advanced Ovarian Cancer
  Full Text via DOI: 10.7759/cureus.16070 Web of Science: 000674085800024
- 2021
  
  Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. JOURNAL OF CLINICAL ONCOLOGY. 39:2037-+.
  Full Text via DOI: 10.1200/JCO.21.00471 Web of Science: 000708045700010
- 2021
  
  Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity. OBSTETRICS AND GYNECOLOGY. 137:423-429.
  Full Text via DOI: 10.1097/AOG.0000000000004275 Web of Science: 000656629800010
- 2019
  
  Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. JOURNAL OF CLINICAL ONCOLOGY. 37:3152-+.
  Full Text via DOI: 10.1200/JCO.19.01472 Web of Science: 000502037600012
- 2019
  
  Approach to the Patient with a Pelvic Mass
  Full Text via DOI: 10.2310/im.1253
- 2019
  
  Approach to the Patient with a Pelvic Mass
  Full Text via DOI: 10.2310/fm.1253
- 2018
  
  Cervical Cancer Prevention And Screening
  Full Text via DOI: 10.2310/fm.1220
- 2017
  
  Cervical Cancer Prevention and Screening
  Full Text via DOI: 10.2310/im.1220
- 2017
  
  Biodistribution and clearance of magnetoelectric nanoparticles for nanomedical applications using energy dispersive spectroscopy. NANOMEDICINE. 12:1801-1822.
  Full Text via DOI: 10.2217/nnm-2017-0080 Web of Science: 000405695800005
- 2016
  
  Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 108.
  Full Text via DOI: 10.1093/jnci/djv350 Web of Science: 000372589400016
- 2016
  
  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. JOURNAL OF CLINICAL ONCOLOGY. 34:611-+.
  Full Text via DOI: 10.1200/JCO.2015.64.3809 Web of Science: 000374332900019
- 2016
  
  Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles. SCIENTIFIC REPORTS. 6.
  Full Text via DOI: 10.1038/srep20867 Web of Science: 000370040700001
- 2013
  
  Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells. SCIENTIFIC REPORTS. 3.
  Full Text via DOI: 10.1038/srep02953 Web of Science: 000325701400001
- 2013
  
  Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline. JOURNAL OF CLINICAL ONCOLOGY. 31:2942-+.
  Full Text via DOI: 10.1200/JCO.2013.49.3122 Web of Science: 000330539300020
- 2012
  
  Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline. JOURNAL OF CLINICAL ONCOLOGY. 30:1553-1561.
  Full Text via DOI: 10.1200/JCO.2011.39.9436 Web of Science: 000303859400028
- 2011
  
  Chemotherapy in Pregnancy. CLINICAL OBSTETRICS AND GYNECOLOGY. 54:602-618.
  Full Text via DOI: 10.1097/GRF.0b013e318236e9f9 Web of Science: 000296579300010
- 2011
  
  Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR). AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 205.
  Full Text via DOI: 10.1016/j.ajog.2011.06.067 Web of Science: 000297329200018
- 2011
  
  Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study
  Full Text via DOI: 10.1016/j.clbc.2011.04.004 Web of Science: 000295450600008
- 2011
  
  Multimodal therapy in the treatment of vaginal adenocarcinoma arising from endocervicosis. GYNECOLOGIC ONCOLOGY. 120:158-159.
  Full Text via DOI: 10.1016/j.ygyno.2010.10.006 Web of Science: 000285824800027
- 2011
  
  Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 18:17-22.
  Full Text via DOI: 10.1097/gme.0b013e3181e84bb4 Web of Science: 000285684100009
- 2010
  
  Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment. GYNECOLOGIC ONCOLOGY. 119:451-456.
  Full Text via DOI: 10.1016/j.ygyno.2010.08.008 Web of Science: 000284556800010
- 2010
  
  Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 20:772-780.
  Full Text via DOI: 10.1111/IGC.0b013e3181daaf59 Web of Science: 000280144000012
- 2010
  
  Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer. CANCER PREVENTION RESEARCH. 3:696-706.
  Full Text via DOI: 10.1158/1940-6207.CAPR-10-0076 Web of Science: 000278374900005
- 2010
  
  Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study. GYNECOLOGIC ONCOLOGY. 116:442-446.
  Full Text via DOI: 10.1016/j.ygyno.2009.10.082 Web of Science: 000275360000031
- 2009
  
  The Impact of the Privacy Rule on Cancer Research: Variations in Attitudes and Application of Regulatory Standards. JOURNAL OF CLINICAL ONCOLOGY. 27:4014-4020.
  Full Text via DOI: 10.1200/JCO.2009.22.3289 Web of Science: 000269064300024
- 2009
  
  POSTMENOPAUSAL EVALUATION AND RISK-REDUCTION WITH LASOFOXIFENE (THE PEARL TRIAL): GYNAECOLOGICAL OUTCOMES AT FIVE-YEARS. MATURITAS. 63:s41.
  Full Text via DOI: 10.1016/s0378-5122(09)70156-2
- 2008
  
  Human Papillomavirus Testing for Primary Cervical Cancer Screening. CURRENT ONCOLOGY REPORTS. 10:533-537.
  Full Text via DOI: 10.1007/s11912-008-0081-0 Web of Science: 000207842800014
- 2008
  
  Intraperitoneal chemotherapy in ovarian cancer: An update
  Full Text via DOI: 10.1097/PPO.0b013e318163c2e0 Web of Science: 000252948000002
- 2007
  
  A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015. CA-A CANCER JOURNAL FOR CLINICIANS. 57:326-340.
  Full Text via DOI: 10.3322/CA.57.6.326
- 2007
  
  Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. GYNECOLOGIC ONCOLOGY. 106:453-460.
  Full Text via DOI: 10.1016/j.ygyno.2007.04.038 Web of Science: 000249361100004
- 2007
  
  Oxaliplatin plus paclitaxel for recurrent and metastatic cervical cancer (CC): New York Cancer Consortium Trial P5840. JOURNAL OF CLINICAL ONCOLOGY. 25:5549-5549.
  Full Text via DOI: 10.1200/jco.2007.25.18_suppl.5549
- 2007
  
  Phase 3 Study: Canfosfamide (C, TLK286) plus carboplatin (P) vs liposomal doxorubicin (D) as 2nd line therapy of platinum (P) resistant ovarian cancer (OC). JOURNAL OF CLINICAL ONCOLOGY. 25:lba5529-lba5529.
  Full Text via DOI: 10.1200/jco.2007.25.18_suppl.lba5529
- 2007
  
  Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia. INTERNATIONAL JOURNAL OF CANCER. 120:55-59.
  Full Text via DOI: 10.1002/ijc.22176 Web of Science: 000242653300008
- 2006
  
  GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. MODERN PATHOLOGY. 19:1429-1436.
  Full Text via DOI: 10.1038/modpathol.3800656 Web of Science: 000241493200006
- 2006
  
  Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. OBSTETRICAL & GYNECOLOGICAL SURVEY. 61:650.
  Full Text via DOI: 10.1097/01.ogx.0000238648.23538.42
- 2006
  
  A midpoint assessment of the American Cancer Society challenge goal to halve the US cancer mortality rates between the years 1990 and 2015. CANCER. 107:396-405.
  Full Text via DOI: 10.1002/cncr.21990 Web of Science: 000238959800022
- 2006
  
  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 295:2727-2741.
  Full Text via DOI: 10.1001/jama.295.23.joc60074 Web of Science: 000238389700028
- 2006
  
  Report of first-stage accrual for NCI 5886, a phase II study of erlotinib, carboplatin and paclitaxel as first-line treatment of ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY. 24:5076-5076.
  Full Text via DOI: 10.1200/jco.2006.24.18_suppl.5076
- 2006
  
  Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: An NYGOG and ECOG study. GYNECOLOGIC ONCOLOGY. 100:324-329.
  Full Text via DOI: 10.1016/j.ygyno.2005.08.059 Web of Science: 000235022800018
- 2006
  
  Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: A brief communication from the New York Phase II consortium. GYNECOLOGIC ONCOLOGY. 100:160-165.
  Full Text via DOI: 10.1016/j.ygyno.2005.08.033 Web of Science: 000234417200029
- 2005
  
  Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 97:1652-1662.
  Full Text via DOI: 10.1093/jnci/dji372 Web of Science: 000233356300008
- 2005
  
  Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia. CLINICAL CANCER RESEARCH. 11:4460-4468.
  Full Text via DOI: 10.1158/1078-0432.CCR-05-0250 Web of Science: 000229725900026
- 2005
  
  An autologous tumor-derived heat shock protein vaccine for high risk ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY. 23:9592-9592.
  Full Text via DOI: 10.1200/jco.2005.23.16_suppl.9592
- 2005
  
  Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY. 23:5052-5052.
  Full Text via DOI: 10.1200/jco.2005.23.16_suppl.5052
- 2004
  
  Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study. GYNECOLOGIC ONCOLOGY. 93:144-148.
  Full Text via DOI: 10.1016/j.ygyno.2003.12.021 Web of Science: 000220850800023
- 2004
  
  Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: Phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group. JOURNAL OF CLINICAL ONCOLOGY. 22:120-126.
  Full Text via DOI: 10.1200/JCO.2004.03.016 Web of Science: 000187796300019
- 2004
  
  Ovarian cancer: not-so-silent. A swollen abdomen, urinary symptoms, and bloating can be warning signs of ovarian cancer, which afflicts 1 in 57 women in the US.
- 2004
  
  Role of plant estrogens in disease remains unclear. Weak estrogens in foods and supplements offer little health protection.
- 2004
  
  Treating abnormal uterine bleeding. Hysterectomy is not always necessary.
- 2004
  
  What is a dropped bladder, and how is it treated?
- 2003
  
  Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 57:208-216.
  Full Text via DOI: 10.1016/S0360-3016(03)00531-5 Web of Science: 000184676100032
- 2003
  
  Evaluation of low-dose intraperitoneal interferon-alpha for palliation of ascites in patients with non-ovarian gynecologic malignancies. GYNECOLOGIC ONCOLOGY. 89:420-423.
  Full Text via DOI: 10.1016/S0090-8258(03)00080-5 Web of Science: 000183682300013
- 2003
  
  Ductal Lavage Screening for Breast Cancer in High-Risk Women in the Gynecologist's Office. OBSTETRICS AND GYNECOLOGY. 101:101s.
  Full Text via DOI: 10.1097/00006250-200304001-00240
- 2003
  
  Ductal Lavage Screening for Breast Cancer in High-Risk Women in the Gynecologist's Office.. OBSTETRICS AND GYNECOLOGY. 101:101s.
  Full Text via DOI: 10.1016/s0029-7844(02)03000-4
- 2003
  
  Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix - Clinical experience with and without concomitant chemotherapy. CANCER. 97:1781-1788.
  Full Text via DOI: 10.1002/cncr.11248 Web of Science: 000181816600023
- 2003
  
  Alternative cancer therapies can be dangerous. "Natural" and "herbal" are not synonymous with "safe".
- 2003
  
  Breast-cancer drug letrozole picks up where tamoxifen leaves off. But we don't know who stands to benefit the most from this follow-up approach.
- 2003
  
  Current therapies in ovarian cancer
  Full Text via DOI: 10.1081/CNV-120016409 Web of Science: 000181475600014
- 2003
  
  Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
- 2003
  
  I've heard that lymphedema can develop after cancer treatment. What is lymphedema, and how is it treated?
- 2003
  
  Low-dose HRT may thwart bone loss. One form of low-dose HRT seems to preserve bone, but its safety remains uncertain.
- 2003
  
  What's my risk of getting an inherited form of breast cancer?
- 2002
  
  Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: Clinical experience with and without chemotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 53:702-706.
  Full Text via DOI: 10.1016/S0360-3016(02)02745-1 Web of Science: 000176539100024
- 2002
  
  Can Radiological Procedures Replace Histologic Examination in the Evaluation of Abnormal Vaginal Bleeding?. OBSTETRICS AND GYNECOLOGY. 99:529-530.
  Full Text via DOI: 10.1097/00006250-200204000-00002
- 2002
  
  Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas
  Full Text via DOI: 10.1097/00004347-200204000-00007 Web of Science: 000174628700007
- 2002
  
  Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervix. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 52:637-642.
  Full Text via DOI: 10.1016/S0360-3016(01)02662-1 Web of Science: 000173999400008
- 2002
  
  Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman. CLINICAL CANCER RESEARCH. 8:549-554.
  Web of Science: 000173908600032
- 2002
  
  A clearer picture of HRT.
- 2002
  
  Hysterectomy options. Total and subtotal surgical procedures prove comparable.
- 2001
  
  Should we offer HRT to ovarian and endometrial cancer survivors? No. The most prudent current approach is to consider alternatives
- 2001
  
  The wisdom of hormone-replacement therapy in survivors of ovarian and endometrial cancer
  Full Text via DOI: 10.1016/S0039-6109(05)70177-8 Web of Science: 000170758400018
- 2001
  
  Allelotype of papillary serous peritoneal carcinomas. GYNECOLOGIC ONCOLOGY. 82:69-76.
  Full Text via DOI: 10.1006/gyno.2001.6176 Web of Science: 000169824900013
- 2001
  
  Fruits, veggies, and breast cancer: time to toss away five-a-day?
- 2001
  
  Herceptin: help for advanced breast cancer.
- 2001
  
  Pattern of lymph node metastases in clinically unilateral stage invasive epithelial ovarian carcinomas. GYNECOLOGIC ONCOLOGY. 80:56-61.
  Full Text via DOI: 10.1006/gyno.2000.6027 Web of Science: 000166389500011
- 2000
  
  Preventing and managing lymphedema
- 2000
  
  Preventing and managing lymphedema
- 2000
  
  HRT and breast cancer.
- 1999
  
  Activity and pharmacodynamics of 21-day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 17:2553-2561.
  Full Text via DOI: 10.1200/JCO.1999.17.8.2553 Web of Science: 000081835300033
- 1999
  
  Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas. GYNECOLOGIC ONCOLOGY. 74:202-207.
  Full Text via DOI: 10.1006/gyno.1999.5446 Web of Science: 000082018800008
- 1999
  
  Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer
  Web of Science: 000080631600008
- 1999
  
  A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY. 72:292-297.
  Full Text via DOI: 10.1006/gyno.1998.5261 Web of Science: 000079015900005
- 1999
  
  2171 Patterns of failure in uterine papillary serous carcinoma (UPSC) suggest a role for whole abdomen radiation therapy (RT) and intravaginal boost. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 45:366.
  Full Text via DOI: 10.1016/s0360-3016(99)90440-6
- 1999
  
  Compliance with Papanicolaou smear screening following tubal ligation in women with cervical cancer
  Full Text via DOI: 10.1089/jwh.1999.8.103 Web of Science: 000079016200017
- 1999
  
  Fibroid face-off.
- 1999
  
  Preventive mastectomy.
- 1998
  
  Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. INTERNATIONAL JOURNAL OF CANCER. 78:594-599.
  Full Text via DOI: 10.1002/(SICI)1097-0215(19981123)78:5<594::AID-IJC11>3.0.CO;2-B Web of Science: 000076772100011
- 1998
  
  CONSERVATIVE MANAGEMENT OF UTERINE RHABDOMYOSARCOMA. OBSTETRICS AND GYNECOLOGY. 92:669-670.
  Full Text via DOI: 10.1097/00006250-199810001-00013
- 1998
  
  Conservative management of uterine rhabdomyosarcoma. OBSTETRICS AND GYNECOLOGY. 92:669-670.
  Full Text via DOI: 10.1016/S0029-7844(98)00240-3 Web of Science: 000076159900013
- 1998
  
  The rectus abdominis myocutaneous flap - Modifications, complications, and sexual function. CANCER. 83:510-520.
  Full Text via DOI: 10.1002/(SICI)1097-0142(19980801)83:3<510::AID-CNCR20>3.0.CO;2-Y Web of Science: 000074982100020
- 1998
  
  Nonhormonal alternatives to treating menopausal symptoms. AMERICAN JOURNAL OF MANAGED CARE. 4:732-738.
  Web of Science: 000073775300008
- 1998
  
  Menopause and controversies in hormone replacement therapy. AMERICAN JOURNAL OF MANAGED CARE. 4:257-262.
  Web of Science: 000072714600008
- 1998
  
  A new alternative to estrogen: raloxifene.
- 1998
  
  Can precolposcopy education increase knowledge and decrease anxiety?. JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING. 27:636-645.
  Full Text via DOI: 10.1111/j.1552-6909.1998.tb02633.x
- 1998
  
  Lymphedema after cancer.
- 1997
  
  Promising advances in ovarian cancer chemotherapy
- 1997
  
  Expression of retinoic acid receptor-beta 2 mRNA in normal cervical epithelium and cervical squamous cell carcinoma. INTERNATIONAL JOURNAL OF ONCOLOGY. 11:983-988.
  Web of Science: A1997YA62300006
- 1997
  
  Mullerian mixed tumors: CT characteristics with clinical and pathologic observations
  Full Text via DOI: 10.2214/ajr.169.2.9242770 Web of Science: A1997XM75800048
- 1997
  
  All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix - Clinical and pharmacokinetic studies. CANCER. 79:1574-1580.
  Full Text via DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1574::AID-CNCR20>3.0.CO;2-U Web of Science: A1997WR20000020
- 1997
  
  Pelvic exenteration for cervix cancer: Would additional intraoperative interstitial brachytherapy improve survival?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 38:143-148.
  Full Text via DOI: 10.1016/S0360-3016(96)00585-8 Web of Science: A1997XG04600021
- 1997
  
  Cervical Neoplasia and Cigarette Smoking: Are They Linked?
- 1997
  
  Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer. GYNECOLOGIC ONCOLOGY. 64:425-430.
  Full Text via DOI: 10.1006/gyno.1996.4559 Web of Science: A1997WP29800009
- 1997
  
  Critical role of phase I clinical trials in cancer treatment. JOURNAL OF CLINICAL ONCOLOGY. 15:853-859.
  Web of Science: A1997WG09800055
- 1997
  
  Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene. CLINICAL CANCER RESEARCH. 3:157-160.
  Web of Science: A1997WY36600003
- 1997
  
  Endometrioid adenocarcinoma of the ovary and long-term tamoxifen therapy: a coincidence or a cause for concern?
  Web of Science: 000071467000004
- 1996
  
  Squamous cell carcinoma in mature cystic teratoma in a young woman: A diagnostic and management dilemma
- 1996
  
  Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry. CLINICAL CANCER RESEARCH. 2:1981-1992.
  Web of Science: A1996VW71800009
- 1996
  
  The Obstetrician‐Gynecologist and the Management of Breast Cancer. BREAST JOURNAL. 2:355-356.
  Full Text via DOI: 10.1111/j.1524-4741.1996.tb00121.x
- 1996
  
  Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix. GYNECOLOGIC ONCOLOGY. 61:416-422.
  Full Text via DOI: 10.1006/gyno.1996.0166 Web of Science: A1996UN88500021
- 1996
  
  Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. CANCER. 77:1107-1114.
  Full Text via DOI: 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.0.CO;2-5 Web of Science: A1996TY62100016
- 1996
  
  Funding for clinical (patient-oriented) oncology research: Current status and recommendations for improvement. JOURNAL OF CLINICAL ONCOLOGY. 14:666-670.
  Web of Science: A1996TU99800048
- 1996
  
  Laparoscopic surgery in patients with a ventriculoperitoneal shunt - A case report
  Web of Science: A1996TW65800013
- 1996
  
  "I hope I don't have cancer": colposcopy and minority women.. ONCOLOGY NURSING FORUM. 23:39-44.
- 1996
  
  Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer. CLINICAL CANCER RESEARCH. 2:181-185.
  Web of Science: A1996TN87800024
- 1995
  
  Lack of efficacy of Interferon-alpha therapy in recurrent, advanced cervical cancer
  Full Text via DOI: 10.1089/jir.1995.15.1011 Web of Science: A1995TM41400001
- 1995
  
  Plasma levels of provitamin A and non-provitamin A carotenoids, retinol, and tocopherols in gynecologic cancers
- 1995
  
  PROMISING NEW THERAPIES IN THE TREATMENT OF ADVANCED OVARIAN-CANCER. CANCER. 76:2028-2033.
  Full Text via DOI: 10.1002/1097-0142(19951115)76:10+<2028::AID-CNCR2820761320>3.0.CO;2-M Web of Science: A1995TE56300018
- 1995
  
  A PROSPECTIVE RANDOMIZED COMPARISON OF AN ATTACHED SILVER-IMPREGNATED CUFF TO PREVENT CENTRAL VENOUS CATHETER-ASSOCIATED INFECTION. GYNECOLOGIC ONCOLOGY. 58:92-100.
  Full Text via DOI: 10.1006/gyno.1995.1189 Web of Science: A1995RG49700016
- 1995
  
  GYNECOLOGICAL EFFECTS OF TAMOXIFEN
  Full Text via DOI: 10.1007/BF01676708 Web of Science: A1995RY34100003
- 1995
  
  A PHASE-I TRIAL OF CYCLOSPHOSPHAMIDE AND CARBOPLATINUM COMBINED WITH INTERLEUKIN-3 IN WOMEN WITH ADVANCED-STAGE OVARIAN-CANCER. GYNECOLOGIC ONCOLOGY. 56:387-394.
  Full Text via DOI: 10.1006/gyno.1995.1068 Web of Science: A1995QQ98000011
- 1995
  
  THE ROLE OF COLONY-STIMULATING FACTOR-1 AND ITS RECEPTOR IN THE ETIOPATHOGENESIS OF ENDOMETRIAL ADENOCARCINOMA. CLINICAL CANCER RESEARCH. 1:313-325.
  Web of Science: A1995RJ52700009
- 1995
  
  Cutaneous metastases from squamous cell carcinoma of the vulva - A case report and review, of the literature
- 1995
  
  Office laparoscopy as a screening tool for early detection of ovarian cancer. JOURNAL OF CELLULAR BIOCHEMISTRY. 238-242.
  Web of Science: A1995TQ51900033
- 1995
  
  Surgical management of patients with endometrial cancer and cervical involvement
- 1994
  
  CLINICAL IMPACT OF CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH GYNECOLOGIC CANCER. JOURNAL OF CLINICAL ONCOLOGY. 12:2317-2320.
  Full Text via DOI: 10.1200/JCO.1994.12.11.2317 Web of Science: A1994PP88000014
- 1994
  
  LIPID-SOLUBLE ANTIOXIDANTS - BETA-CAROTENE AND ALPHA-TOCOPHEROL LEVELS IN BREAST AND GYNECOLOGIC CANCERS. GYNECOLOGIC ONCOLOGY. 55:72-77.
  Full Text via DOI: 10.1006/gyno.1994.1250 Web of Science: A1994PP04600015
- 1994
  
  SINGLE-USE PERCUTANEOUS CATHETERS FOR INTRAPERITONEAL P-32 THERAPY. CANCER. 73:2633-2637.
  Full Text via DOI: 10.1002/1097-0142(19940515)73:10<2633::AID-CNCR2820731027>3.0.CO;2-Z Web of Science: A1994NL99300026
- 1994
  
  DNA-ADDUCTS IN HUMAN AND PATAS MONKEY MATERNAL AND FETAL TISSUES INDUCED BY PLATINUM DRUG CHEMOTHERAPY
  Full Text via DOI: 10.1016/0890-6238(94)90004-3 Web of Science: A1994NQ43700003
- 1994
  
  Dose escalation combination carboplatin/cyclophosphamide chemotherapy for epithelial ovarian cancer
- 1994
  
  Vaginal apex recurrence in patients with early stage endometrial cancer treated by postoperative external beam rt without intravaginal boost. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 30:282.
  Full Text via DOI: 10.1016/0360-3016(94)90847-8
- 1993
  
  PILOT TRIAL OF CISPLATIN, RADIATION, AND WR2721 IN CARCINOMA OF THE UTERINE CERVIX - A NEW-YORK GYNECOLOGIC-ONCOLOGY-GROUP STUDY. JOURNAL OF CLINICAL ONCOLOGY. 11:1511-1516.
  Web of Science: A1993LR48000012
- 1993
  
  CANCER SCREENING FOR WOMEN OLDER THAN 40 YEARS OF AGE. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA. 20:391-408.
  Web of Science: A1993LG15600012
- 1993
  
  PLATINUM CHEMOTHERAPY DURING PREGNANCY FOR SEROUS CYSTADENOCARCINOMA OF THE OVARY. GYNECOLOGIC ONCOLOGY. 49:92-94.
  Full Text via DOI: 10.1006/gyno.1993.1092 Web of Science: A1993LB92300018
- 1993
  
  TAXOL IN OVARIAN-CANCER. CANCER. 71:1591-1596.
  Full Text via DOI: 10.1002/cncr.2820710442 Web of Science: A1993KN46700028
- 1993
  
  MULTIMODALITY THERAPY IN LOCALLY ADVANCED CERVICAL-CANCER. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY. 5:92-98.
  Web of Science: A1993KN03600016
- 1993
  
  Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. JOURNAL OF CLINICAL ONCOLOGY. 11:1517-1522.
  Full Text via DOI: 10.1200/JCO.1993.11.8.1517
- 1993
  
  Phase I trial of pixy321 in combination with cyclophosphamide (Cy) and carboplatin (Carb) in women with ovarian cancer (OC). EUROPEAN JOURNAL OF CANCER. 29:s52.
  Full Text via DOI: 10.1016/0959-8049(93)90879-k
- 1993
  
  Preoperative Transcatheter Embolization of Abdominal Pregnancy: Report of Three Cases. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 4:733-735.
  Full Text via DOI: 10.1016/S1051-0443(93)71960-0
- 1992
  
  LYMPH-NODE SAMPLING IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA. GYNECOLOGIC ONCOLOGY. 47:143-145.
  Full Text via DOI: 10.1016/0090-8258(92)90097-3 Web of Science: A1992KE78200003
- 1992
  
  PHASE-II STUDY AND LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH TAXOL FOR ADVANCED OVARIAN ADENOCARCINOMA. JOURNAL OF CLINICAL ONCOLOGY. 10:1748-1753.
  Full Text via DOI: 10.1200/JCO.1992.10.11.1748 Web of Science: A1992JV90000013
- 1992
  
  Lymph node sampling in patients with epithelial ovarian carcinoma. GYNECOLOGIC ONCOLOGY. 45:77.
  Full Text via DOI: 10.1016/0090-8258(92)90501-9
- 1992
  
  Pilot clinical trial of cisplatin (CDDP), radiation therapy (RT), and WR2721 in carcinoma of the uterine cervix (CC). GYNECOLOGIC ONCOLOGY. 45:85.
  Full Text via DOI: 10.1016/0090-8258(92)90531-m
- 1992
  
  Surgical management of patients with endometrial cancer and cervical involvement. GYNECOLOGIC ONCOLOGY. 45:97-98.
  Full Text via DOI: 10.1016/0090-8258(92)90583-5
- 1992
  
  CA‐125: A potential prognostic indicator in patients with cervical cancer?. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 37:329-329.
  Full Text via DOI: 10.1016/0020-7292(92)90360-u
- 1992
  
  OVARIAN-CARCINOMA OF LOW MALIGNANT POTENTIAL, INFERTILITY, AND INDUCTION OF OVULATION - IS THERE A LINK. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 166:853-854.
  Full Text via DOI: 10.1016/0002-9378(92)91348-E Web of Science: A1992HJ88500016
- 1991
  
  CA-125 - A POTENTIAL PROGNOSTIC INDICATOR IN PATIENTS WITH CERVICAL-CANCER. GYNECOLOGIC ONCOLOGY. 40:222-224.
  Web of Science: A1991FF76200005
- 1991
  
  CA125-a potential prognostic indicator in patients with cervical carcinoma?. GYNECOLOGIC ONCOLOGY. 40:189.
  Full Text via DOI: 10.1016/0090-8258(91)90205-j
- 1991
  
  The role of anemia in predicting treatment outcome in locally advanced cervical carcinoma. GYNECOLOGIC ONCOLOGY. 40:186.
  Full Text via DOI: 10.1016/0090-8258(91)90189-c
- 1990
  
  A SUCCESSFUL TERM PREGNANCY FOLLOWING THE SYSTEMIC AND INTRAPERITONEAL ADMINISTRATION OF CISPLATIN CHEMOTHERAPY. GYNECOLOGIC ONCOLOGY. 39:378-380.
  Full Text via DOI: 10.1016/0090-8258(90)90270-U Web of Science: A1990EP34000027
- 1990
  
  HETEROGENEITY IN HORMONE RECEPTOR STATUS IN PRIMARY AND METASTATIC ENDOMETRIAL CANCER. GYNECOLOGIC ONCOLOGY. 38:437-441.
  Full Text via DOI: 10.1016/0090-8258(90)90087-2 Web of Science: A1990EE33000026
- 1990
  
  OVARIAN CONSERVATION IN PLACENTAL SITE TROPHOBLASTIC TUMOR. GYNECOLOGIC ONCOLOGY. 37:239-243.
  Full Text via DOI: 10.1016/0090-8258(90)90340-Q Web of Science: A1990DE81300014
- 1989
  
  A RAPID DNA PROBE TEST FOR DETECTING HUMAN PAPILLOMA-VIRUS TYPES 6/11 AND 16 IN BIOPSY SPECIMENS
  Full Text via DOI: 10.1016/0890-8508(89)90008-X Web of Science: A1989AR25500008
- 1989
  
  CONCOMITANT CISPLATIN AND RADIOTHERAPY IN LOCALLY ADVANCED CERVICAL-CARCINOMA. GYNECOLOGIC ONCOLOGY. 34:395-401.
  Full Text via DOI: 10.1016/0090-8258(89)90180-7 Web of Science: A1989AN07200026
- 1989
  
  ARTERIAL EMBOLIZATION IN THE MANAGEMENT OF ABDOMINAL AND RETROPERITONEAL HEMORRHAGE. GYNECOLOGIC ONCOLOGY. 34:131-135.
  Full Text via DOI: 10.1016/0090-8258(89)90127-3 Web of Science: A1989AG45100001
- 1989
  
  COLPOSCOPIC AND CYTOLOGIC DETECTION OF CHRONIC LYMPHOCYTIC-LEUKEMIA. GYNECOLOGIC ONCOLOGY. 34:106-108.
  Full Text via DOI: 10.1016/0090-8258(89)90118-2 Web of Science: A1989AC05800025
- 1989
  
  IMMUNE-COMPLEXES IN OVARIAN-CARCINOMA. GYNECOLOGIC ONCOLOGY. 32:350-353.
  Full Text via DOI: 10.1016/0090-8258(89)90638-0 Web of Science: A1989T498400017
- 1989
  
  CA-125 LEVELS IN PATIENTS WITH OVARIAN-CARCINOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 160:354-355.
  Full Text via DOI: 10.1016/0002-9378(89)90442-0 Web of Science: A1989T280500017
- 1989
  
  Concomitant cisplatin (DDP) and radiotherapy (RT) in locally advanced cervical carcinoma (CX CA). GYNECOLOGIC ONCOLOGY. 32:126-127.
  Full Text via DOI: 10.1016/0090-8258(89)90998-0
- 1989
  
  Incidence of clostridium difficile (CD) infection in patients (pis.) with diarrhea (D) on a gynecologic oncology service. GYNECOLOGIC ONCOLOGY. 32:120.
  Full Text via DOI: 10.1016/0090-8258(89)90968-2
- 1989
  
  PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THIOTEPA ADMINISTERED INTRAPERITONEALLY IN PATIENTS WITH ADVANCED MALIGNANCIES. JOURNAL OF CLINICAL ONCOLOGY. 7:132-139.
  Full Text via DOI: 10.1200/JCO.1989.7.1.132 Web of Science: A1989R711000019
- 1988
  
  ADENOCARCINOMA ARISING IN VULVAR BREAST-TISSUE. CANCER. 62:2234-2238.
  Full Text via DOI: 10.1002/1097-0142(19881115)62:10<2234::AID-CNCR2820621027>3.0.CO;2-F Web of Science: A1988Q718400026
- 1988
  
  CONTINUOUS INFUSION FLUOROPYRIMIDINES AS SALVAGE THERAPY FOR PATIENTS WITH ADVANCED OVARIAN-CARCINOMA. GYNECOLOGIC ONCOLOGY. 29:348-355.
  Full Text via DOI: 10.1016/0090-8258(88)90234-X Web of Science: A1988M440200010
- 1987
  
  A CRITICAL-ASSESSMENT OF THE ROLE OF 2ND-LOOK SURGERY IN OVARIAN-CARCINOMA
  Full Text via DOI: 10.3109/07357908709032905 Web of Science: A1987M071600010
- 1986
  
  CATHETER COMPLICATIONS ASSOCIATED WITH INTRAPERITONEAL CHEMOTHERAPY. GYNECOLOGIC ONCOLOGY. 24:41-50.
  Full Text via DOI: 10.1016/0090-8258(86)90006-5 Web of Science: A1986C116100006
- 1985
  
  THE ASSESSMENT OF FETAL PULMONARY MATURITY BY FLUORESCENCE POLARIZATION (FP-VALUE) OF POOLED VAGINAL AMNIOTIC-FLUID ASSOCIATED WITH RUPTURED MEMBRANES. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 23:481-488.
  Full Text via DOI: 10.1016/0020-7292(85)90073-6 Web of Science: A1985AXJ5500008
- 1985
  
  CLINICAL ASPECTS OF GESTATIONAL TROPHOBLASTIC DISEASE (REPRINTED FROM MEDICAL, SURGICAL, AND GYNECOLOGIC COMPLICATIONS OF PREGNANCY, 1985)
  Web of Science: A1985ABB1200006
- 1985
  
  ELEVATION OF SERUM CA 125 PRIOR TO DIAGNOSIS OF AN EPITHELIAL OVARIAN-CARCINOMA. GYNECOLOGIC ONCOLOGY. 22:115-120.
  Full Text via DOI: 10.1016/0090-8258(85)90015-0 Web of Science: A1985ANF4800015
- 1980
  
  SINUSOIDAL FETAL HEART-RATE PATTERN IN ASSOCIATION WITH AMNIONITIS. OBSTETRICS AND GYNECOLOGY. 56:109-112.
  Web of Science: A1980JY65300024
- American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA-A CANCER JOURNAL FOR CLINICIANS. 52:342-362.
  Full Text via DOI: 10.3322/canjclin.52.6.342 Web of Science: 000179559500004
- American Cancer Society guidelines for the early detection of cancer. CA-A CANCER JOURNAL FOR CLINICIANS. 52:8-22.
  Full Text via DOI: 10.3322/canjclin.52.1.8 Web of Science: 000173355700002
- Hormone replacement therapy in cancer survivors: A con opinion. CA-A CANCER JOURNAL FOR CLINICIANS. 46:365-+.
  Full Text via DOI: 10.3322/canjclin.46.6.365 Web of Science: A1996VX18500004
- Ovarian Cancer Statistics, 2018. CA-A CANCER JOURNAL FOR CLINICIANS. 68:284-296.
  Full Text via DOI: 10.3322/caac.21456 Web of Science: 000439923200006
Book
- 2005
  
  The Answer to Cancer Stop It before It Starts, Arrest It in Its Earliest Stages, Prevent It from Coming Back
- 2004
  
  The Answer to Cancer
Book Chapter
- 2018
  
  Cervical Cancer. 288-303.
  Full Text via DOI: 10.1002/9781118592168.ch21
- 2018
  
  Vaginal Cancer. 304-309.
  Full Text via DOI: 10.1002/9781118592168.ch22
- 2018
  
  Vulvar Cancer. 310-317.
  Full Text via DOI: 10.1002/9781118592168.ch23
- 2004
  
  Evaluation of gynecologic tumor response: When and how?. 173-186.
- 2004
  
  Hormone replacement in the patient with uterine cancer. 495-506.
- 2003
  
  Chapter 18 Early Diagnosis and Screening for Ovarian Cancer. 219-229.
  Full Text via DOI: 10.1016/b978-012053642-9/50023-5
- 2003
  
  Early Diagnosis and Screening for Ovarian Cancer. 219-229.
  Full Text via DOI: 10.1016/B978-012053642-9/50023-5
Conference
- 2018
  
  The MD CaREs initiative: Tailoring oncology education to ethnically and culturally diverse students.. JOURNAL OF CLINICAL ONCOLOGY.
  Full Text via DOI: 10.1200/JCO.2018.36.15_suppl.11019 Web of Science: 000442916003582
- 2017
  
  Magnetoelectric nanoparticles for high-specificity treatment of cancer. CANCER RESEARCH.
  Full Text via DOI: 10.1158/1538-7445.AM2017-2199 Web of Science: 000442496705056
- 2016
  
  Abstract 2204: Targeted, controlled anticancer drug delivery and release with magnetoelectric nanoparticles. CANCER RESEARCH. 2204-2204.
  Full Text via DOI: 10.1158/1538-7445.am2016-2204
- 2016
  
  Magnetoelectric particles cross blood brain barrier to deliver anti-tumor peptide to glioblastoma cells with on-demand release. CANCER RESEARCH.
  Full Text via DOI: 10.1158/1538-7445.AM2016-1346 Web of Science: 000389940600183
- 2016
  
  A novel mechanism for field-controlled high-specificity targeted anticancer drug delivery and on-demand release using magnetoelectric nanoparticles. CANCER RESEARCH.
  Full Text via DOI: 10.1158/1538-7445.FBCR15-B47 Web of Science: 000374159700071
- 2013
  
  Continuous combined oestrogen plus progestin and endometrial cancer in postmenopausal women in the Women's Health Initiative randomized clinical trial. EUROPEAN JOURNAL OF CANCER. S7-S7.
  Web of Science: 000209470600018
- 2011
  
  Early Detection of Cardiotoxicity by Advanced Cardiac Imaging and a Novel Biomarker in Breast Cancer Patients Undergoing Chemotherapy.. CANCER RESEARCH.
  Full Text via DOI: 10.1158/0008-5472.SABCS11-OT1-02-12 Web of Science: 000209699801018
- 2007
  
  Oxaliplatin plus paclitaxel for recurrent and metastatic cervical cancer (CC): New York Cancer Consortium Trial P5840. JOURNAL OF CLINICAL ONCOLOGY.
  Web of Science: 000455043701329
- 2005
  
  Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer.. JOURNAL OF CLINICAL ONCOLOGY. 467S-467S.
  Web of Science: 000230326603095
- 2005
  
  Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 1230-1237.
  Full Text via DOI: 10.1016/j.ajog.2004.12.083 Web of Science: 000228421800039
- 2003
  
  Innovations in understanding the biology of cervical cancer. CANCER. 2064-2069.
  Full Text via DOI: 10.1002/cncr.11682 Web of Science: 000186236300009
- 2002
  
  Surgery "ain't" going to cut it. Are we ready?. GYNECOLOGIC ONCOLOGY. 357-359.
  Full Text via DOI: 10.1006/gyno.2001.6421 Web of Science: 000174372100001
- 1998
  
  Lymphedema: Patient and provider education - Current status and future trends. CANCER. 2874-2876.
  Full Text via DOI: 10.1002/(SICI)1097-0142(19981215)83:12B+<2874::AID-CNCR42>3.0.CO;2-4 Web of Science: 000077732500019
- 1998
  
  Workgroup II - Patient education - Pre- and posttreatment. CANCER. 2880-+.
  Full Text via DOI: 10.1002/(SICI)1097-0142(19981215)83:12B+<2880::AID-CNCR44>3.0.CO;2-9 Web of Science: 000077732500021
- 1998
  
  PSC833: Initial clinical results in refractory ovarian cancer patients
- 1998
  
  BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 670-677.
  Full Text via DOI: 10.1016/S0002-9378(98)70476-4 Web of Science: 000073362100005
- 1996
  
  The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix. 64-68.
  Web of Science: A1996VG26000011
- 1996
  
  Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 1151-1159.
  Full Text via DOI: 10.1016/S0002-9378(96)70657-9 Web of Science: A1996UH18400016
Letter
- 2008
  
  Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer - Reply. NEW ENGLAND JOURNAL OF MEDICINE. 644-644.
  Web of Science: 000252916400020
- 2008
  
  Patients' competence to consent to treatment. NEW ENGLAND JOURNAL OF MEDICINE. 644-644.
  Web of Science: 000252916400021
- 2006
  
  Clarifying cancer mortality rates. SCIENCE. 171-172.
  Web of Science: 000239008000021
- 2006
  
  Benign gynecologic conditions in Tamoxifen-treated patients - Reply. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 1205-1205.
  Full Text via DOI: 10.1016/j.ajog.2005.07.063 Web of Science: 000236596800069
- 2002
  
  Association of tamoxifen and uterine sarcoma. JOURNAL OF CLINICAL ONCOLOGY. 2758-2760.
  Full Text via DOI: 10.1200/JCO.2002.20.11.2758 Web of Science: 000175890000026
- 1998
  
  Profound thrombocytopenia in previously treated patients with recurrent ovarian carcinoma receiving topotecan. GYNECOLOGIC ONCOLOGY. 175-176.
  Full Text via DOI: 10.1006/gyno.1998.4966 Web of Science: 000073987900018
- 1994
  
  ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP)-B-14. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 1252-1253.
  Full Text via DOI: 10.1093/jnci/86.16.1252 Web of Science: A1994PB10300019
- 1994
  
  MORE ON THE WOMENS HEALTH INITIATIVE. NEW ENGLAND JOURNAL OF MEDICINE. 1619-1619.
  Web of Science: A1994NN21500031
- 1987
  
  REVERSIBLE CENTRAL NERVOUS-SYSTEM TOXICITY ASSOCIATED WITH HIGH-DOSE CHLORAMBUCIL IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR OVARIAN-CARCINOMA. 1324-1325.
  Web of Science: A1987L626000050
- 1987
  
  DETECTION OF HUMAN PAPILLOMAVIRUS TYPE 16 DNA IN PERITONEAL WASHINGS FROM PATIENTS WITH CERVICAL-CARCINOMA. JOURNAL OF INFECTIOUS DISEASES. 1349-1349.
  Full Text via DOI: 10.1093/infdis/155.6.1349 Web of Science: A1987H341300046
- 1981
  
  FLUORESCENCE POLARIZATION - COMMENTS ON URINE CONTAMINATION. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 613-614.
  Full Text via DOI: 10.1016/0002-9378(81)90535-4 Web of Science: A1981LG32300030
- CORRECTION IN OVARIAN-CANCER ARTICLE. CA-A CANCER JOURNAL FOR CLINICIANS. 191-192.
  Full Text via DOI: 10.3322/canjclin.43.3.191 Web of Science: A1993LC19600006
Note
- 1995
  
  AUDIOLOGICAL FINDINGS IN A PHASE-I PROTOCOL INVESTIGATING THE EFFECT OF WR-2721, HIGH-DOSE CISPLATIN AND RADIATION-THERAPY IN PATIENTS WITH LOCALLY ADVANCED CERVICAL-CARCINOMA. 744-747.
  Full Text via DOI: 10.1017/S0022215100131202 Web of Science: A1995RP96200011
- 1994
  
  EARLY DETECTION OF ABDOMINAL PREGNANCY BY MATERNAL SERUM AFP+ SCREENING. PRENATAL DIAGNOSIS. 1155-1157.
  Full Text via DOI: 10.1002/pd.1970141209 Web of Science: A1994QF67700008
- 1994
  
  CECAL CANCER IN A TEENAGER PRESENTING WITH A PELVIC MASS - A CASE-REPORT AND REVIEW OF THE LITERATURE. GYNECOLOGIC ONCOLOGY. 149-151.
  Full Text via DOI: 10.1006/gyno.1994.1265 Web of Science: A1994PP04600030
Other Scholarly Work
- 2020
  
  Florida International University Herbert Wertheim College of Medicine. ACADEMIC MEDICINE. S103-S106.
  Full Text via DOI: 10.1097/ACM.0000000000003282 Web of Science: 000619186200027
- 2016
  
  Targeted, controlled anticancer drug delivery and release with magnetoelectric nanoparticles. CANCER RESEARCH.
  Full Text via DOI: 10.1158/1538-7445.AM2016-2204 Web of Science: 000389940600268
- 2015
  
  In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. MAYO CLINIC PROCEEDINGS. 996-1000.
  Full Text via DOI: 10.1016/j.mayocp.2015.06.001 Web of Science: 000359138000005
- 2015
  
  Final updated results of the NRG Oncology/NSABP Protocol P-2: Study of Tamoxifen and Raloxifene (STAR) in preventing breast cancer. JOURNAL OF CLINICAL ONCOLOGY.
  Full Text via DOI: 10.1200/jco.2015.33.15_suppl.1500 Web of Science: 000358036900367
- 2010
  
  Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites. 114-117.
  Full Text via DOI: 10.1200/JOP.200028 Web of Science: 000214289300002
- 2007
  
  Molecular screening for cervical cancer - Time to give up pap tests?.. NEW ENGLAND JOURNAL OF MEDICINE. 1650-1653.
  Full Text via DOI: 10.1056/NEJMe078155 Web of Science: 000250200500012
- 2006
  
  Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery?. 416-417.
  Full Text via DOI: 10.1038/ncponc0556 Web of Science: 000239341100003
- 2006
  
  Investment in cancer control and research: A sure bet. CA-A CANCER JOURNAL FOR CLINICIANS. 9-10.
  Full Text via DOI: 10.3322/canjclin.56.1.9 Web of Science: 000235542000006
- 2005
  
  Saul B. Gusberg, MD. In memoriam. GYNECOLOGIC ONCOLOGY. 339-340.
  Full Text via DOI: 10.1016/j.ygyno.2005.07.101 Web of Science: 000232014000001
- 2004
  
  Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. OBSTETRICS AND GYNECOLOGY. 304-309.
  Full Text via DOI: 10.1097/01.AOG.0000109426.82624.f8 Web of Science: 000225413600015
- 2003
  
  American cancer society guideline for the early detection of cervical neoplasia and cancer (vol 52, pg 342, 2002). CA-A CANCER JOURNAL FOR CLINICIANS. 127-127.
  Web of Science: 000182104500006
- 2003
  
  Erratum: "American Cancer Society Guideline for the early detection of cervical neoplasia and cancer" (CA Cancer Journal for Clinicians (2002) vol. 52 (342-362)). CA-A CANCER JOURNAL FOR CLINICIANS. 127.
- 2002
  
  Can radiological procedures replace histologic examination in the evaluation of abnormal vaginal bleeding?. OBSTETRICS AND GYNECOLOGY. 529-530.
  Full Text via DOI: 10.1097/00006250-200204000-00002 Web of Science: 000174635200002
- 2001
  
  Erratum: "American cancer society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancer" (CA A Cancer Journal for Clinicians) (2001) vol. 51 (38-75)). CA-A CANCER JOURNAL FOR CLINICIANS. 373.
- 2000
  
  Gynecologic surveillance of women on tamoxifen: First do no harm. JOURNAL OF CLINICAL ONCOLOGY. 3457-3458.
  Full Text via DOI: 10.1200/JCO.2000.18.20.3457 Web of Science: 000090077100001
- 1996
  
  Access to cancer care and clinical trials: A time for reappraisal. WOMENS HEALTH ISSUES. 112-113.
  Web of Science: A1996UB80200008
- 1995
  
  Erratum: Re: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 (Journal of the National Cancer Institute (1994) 86 (1252-1253)). JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 540.
- 1995
  
  Erratum: Re: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 (Journal of the National Cancer Institute (1994) 86 (1252-1253)). JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 610.
- 1993
  
  TO P-32 OR NOT TO P-32, THAT IS THE QUESTION. GYNECOLOGIC ONCOLOGY. 139-140.
  Full Text via DOI: 10.1006/gyno.1993.1182 Web of Science: A1993LY18800001
Review
- 2010
  
  Ovarian cancer immunotherapy: opportunities, progresses and challenges
  Full Text via DOI: 10.1186/1756-8722-3-7 Web of Science: 000275447000001
- 2010
  
  The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer. GYNECOLOGIC ONCOLOGY. 282-285.
  Full Text via DOI: 10.1016/j.ygyno.2009.10.085 Web of Science: 000274504200021
- 2009
  
  Ovarian cancer screening and early detection. 693-699.
  Full Text via DOI: 10.2217/WHE.09.65 Web of Science: 000213102000016
- 2009
  
  American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. JOURNAL OF CLINICAL ONCOLOGY. 3235-3258.
  Full Text via DOI: 10.1200/JCO.2008.20.5179 Web of Science: 000267454100027
- 2009
  
  American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. 196-199.
  Full Text via DOI: 10.1200/JOP.0948502
- 2005
  
  Cervical cancer screening. 777-797.
  Full Text via DOI: 10.1016/j.soc.2005.05.011
- 2003
  
  American Cancer Society guideline for the early detection of cervical neoplasia and cancer. 67-86.
  Full Text via DOI: 10.1097/00128360-200304000-00001
- 2002
  
  Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.. 163-169.
- 1999
  
  Screening for gynecologic malignancies: A continuing responsibility. 703-723.
  Full Text via DOI: 10.1016/s1055-3207(18)30184-4
- 1992
  
  ADVANCES IN THE SCREENING AND TREATMENT OF OVARIAN-CANCER. CA-A CANCER JOURNAL FOR CLINICIANS. 327-349.
  Full Text via DOI: 10.3322/canjclin.42.6.327 Web of Science: A1992JW93400002
- 1991
  
  ADJUVANT THERAPY FOR NEUROENDOCRINE SMALL-CELL CARCINOMA OF THE CERVIX - REVIEW OF THE LITERATURE. GYNECOLOGIC ONCOLOGY. 167-172.
  Full Text via DOI: 10.1016/0090-8258(91)90066-E Web of Science: A1991GU86400016
- American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers - ALSO: Update 2001 - Testing for early lung cancer detection. CA-A CANCER JOURNAL FOR CLINICIANS. 38-75.
  Full Text via DOI: 10.3322/canjclin.51.1.38 Web of Science: 000166879300003
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA-A CANCER JOURNAL FOR CLINICIANS. 44-73.
  Full Text via DOI: 10.3322/caac.21319 Web of Science: 000371886000005
- Preserving fertility after cancer. CA-A CANCER JOURNAL FOR CLINICIANS. 211-228.
  Full Text via DOI: 10.3322/canjclin.55.4.211 Web of Science: 000231484300005

co-principal investigator on

Grant
- Nano-electroporation for high-specificity drug uptake using magneto-electric nanoparticles awarded by National Science Foundation 2014 - 2018

ORCID iD

https://orcid.org/0000-0002-6246-3743 (confirmed)

visualizations

Co-author Network

Co-investigator Network

publication subject areas

Citation index-derived subject areas the researcher has published in